PerceptiMed

About:

PerceptiMed develops an advanced pill identification system designed to eliminate human errors in medication dispensing in pharmacies.

Website: http://www.perceptimed.com

Twitter/X: perceptimed

Top Investors: New Science Ventures, Easton Capital, Latterell Venture Partners, Prairie Ventures

Description:

PerceptiMed’s groundbreaking VeriFill™ technology reduces the margin of human error in prescription pill dispensing within retail pharmacies, long-term care facilities and hospitals. Its IdentRx™suite of medication verification and dispensing products are fast, accurate and cost-effective -- providing 100% verification of drug, dosage and manufacturer for every pill, every time.

Total Funding Amount:

$11M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Mountain View, California, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)perceptimed.com

Founders:

Alan Jacobs, Alan Jacobs, Jennifer Jacob

Number of Employees:

11-50

Last Funding Date:

2018-09-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai